Valuation: CVRx, Inc.

Market Cap 2.47Cr 2.22Cr 2.03Cr 1.85Cr 3.49Cr 232.61Cr 3.6Cr 24Cr 9.75Cr 124.11Cr 9.29Cr 9.09Cr 391.82Cr P/E 2026 *
-0.42x
P/E 2027 * -0.47x
Enterprise Value 3.52Cr 3.16Cr 2.89Cr 2.64Cr 4.97Cr 331.34Cr 5.13Cr 35Cr 14Cr 176.8Cr 13Cr 13Cr 558.13Cr EV / Sales 2026 *
0.63x
EV / Sales 2027 * 1.12x
Free-Float
85.05%
Yield 2026 *
-
Yield 2027 * -
1 day-40.90%
1 week-38.39%
Current month-38.39%
1 month-47.98%
3 months-63.65%
6 months-88.13%
Current year-87.76%
1 week 0.77
Extreme 0.774099
1.6
1 month 0.77
Extreme 0.774099
1.68
Current year 0.77
Extreme 0.774099
9.84
1 year 0.77
Extreme 0.774099
10.28
3 years 0.77
Extreme 0.774099
33.14
5 years 0.77
Extreme 0.774099
33.14
10 years 0.77
Extreme 0.774099
33.14
Manager TitleAgeSince
Chief Executive Officer 60 12/02/2024
Director of Finance/CFO 54 12/10/2026
Director of Finance/CFO 43 01/10/2020
Director TitleAgeSince
Director/Board Member 61 01/10/2008
Director/Board Member 57 01/07/2020
Director/Board Member 52 01/07/2020
Date Insider Type Main position Quantity % Market Cap. Importance
13/08/26 Buy

Chief Operating Officer

26,223 0.0988%
12/08/26 Sell

Chief Operating Officer

-1,309 0.0049%
01/06/26
Treo Ventures LLC
OtherCompany 0 0% -
Change 5-day change 1-year change 3-year change Capi.($)
-40.90%-38.39%-91.05%-94.88% 2.47Cr
-3.23%+3.51%-13.00%+15.96% 19TCr
-2.90%+5.45%+10.41%+40.45% 12TCr
-2.75%+11.65%-8.47%+18.50% 12TCr
+0.96%+5.15%-37.16%+12.09% 9.93TCr
-1.80%+0.82%-7.52%+70.12% 6.37TCr
-0.78%+7.07%+19.14%-17.27% 5.77TCr
+0.79%+22.65%-4.57%+60.02% 5.33TCr
-6.98%-14.56%-11.97%+46.23% 4.7TCr
-2.36%+3.72%+3.86%-7.99% 3.62TCr
Average -5.99%+0.90%-14.03%+14.32% 7.96TCr
Weighted average by Cap. -2.20%+5.71%-7.49%+25.27%

Financials

2026 *2027 *
Net sales 5.64Cr 5.06Cr 4.62Cr 4.22Cr 7.95Cr 530.14Cr 8.2Cr 56Cr 22Cr 282.87Cr 21Cr 21Cr 893Cr 6.05Cr 5.43Cr 4.96Cr 4.53Cr 8.54Cr 569.18Cr 8.81Cr 60Cr 24Cr 303.7Cr 23Cr 22Cr 958.76Cr
Net income -5.35Cr -4.79Cr -4.38Cr -4Cr -7.54Cr -502.46Cr -7.77Cr -53Cr -21Cr -268.1Cr -20Cr -20Cr -846.37Cr -5.21Cr -4.68Cr -4.27Cr -3.9Cr -7.35Cr -490.08Cr -7.58Cr -52Cr -21Cr -261.5Cr -20Cr -19Cr -825.53Cr
Net Debt 1.05Cr 94.2L 86.09L 78.59L 1.48Cr 99Cr 1.53Cr 10Cr 4.14Cr 53Cr 3.94Cr 3.86Cr 166.31Cr 4.29Cr 3.85Cr 3.52Cr 3.21Cr 6.05Cr 403.63Cr 6.24Cr 42Cr 17Cr 215.37Cr 16Cr 16Cr 679.9Cr
Projected Income Statement - Annual - CVRx, Inc.
Logo CVRx, Inc.
CVRx, Inc. is a commercial-stage medical device company. The Company is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The Company's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programmed by a wireless clinician-controlled programmer that communicates with the IPG.
Employees
223
Date Price Change Volume
06/26/06 $0.8687 -40.90% 53,96,532
05/26/05 $1.470 -6.96% 2,99,478
04/26/04 $1.580 +14.49% 3,68,168
03/26/03 $1.380 +0.73% 3,05,339
02/26/02 $1.370 -2.84% 2,94,148
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - CVRx, Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
0.8687USD
Average target price
4.083USD
Spread / Average Target
+370.05%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - CVRx, Inc.
  1. Stock Market
  2. Stocks
  3. CVRX Stock